BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0104
0.00 (0.00%)
Apr 20, 2026, 1:08 PM EST
BioRegenx Revenue
In the year 2025, BioRegenx had annual revenue of $1.85M, down -20.75%. BioRegenx had revenue of $385.64K in the quarter ending December 31, 2025, a decrease of -16.25%.
Revenue
1.85M
Revenue Growth
-20.75%
P/S Ratio
5.43
Revenue / Employee
370.90K
Employees
5
Market Cap
10.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.85M | -485.59K | -20.75% |
| Dec 31, 2024 | 2.34M | -1.07M | -31.40% |
| Dec 31, 2023 | 3.41M | 3.37M | 7,991.78% |
| Dec 31, 2022 | 42.16K | -3.95M | -98.94% |
| Dec 31, 2021 | 3.99M | -3.80M | -48.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veri Medtech Holdings | 11.89M |
| CareView Communications | 9.02M |
| Pharma-Bio Serv | 8.82M |
| DATATRAK International | 6.50M |
| CompuMed | 1.69M |
BioRegenx News
- 1 year ago - BioRegenx, Inc. Engages Sichenzia Ross Ference Carmel LLP for Legal Representation in Connection with Planned Uplisting to National Stock Exchange - Accesswire